Esperion Therapeutics shares rise 4.57% premarket after announcing participation in September investor events.

Esperion Therapeutics, Inc. rose 4.57% in premarket trading, with the company announcing its participation in upcoming investor events in September. These events include the Cantor Global Healthcare Conference on September 3, 2025, and the H.C. Wainwright 27th Annual Global Investment Conference on September 8, 2025. The company's participation in these events is likely to attract investor attention and potentially drive up the stock price.